Neurelis
Manufacturing · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3430 Carmel Mountain Rd Ste 300, San Die...Phone Number
(858) 251-2100Website
www.neurelis.comRevenue
$8.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Neurelis
Neurelis is changing the way central nervous system (CNS) disorders are treated. In 2007, a small group of individuals who were passionate about helping patients started Neurelis in San Diego, California. Our founders identified significant unmet needs for patients, care partners, and healthcare providers in the treatment of CNS disorders and are working to develop treatments that are safe and effective to meet those needs.Explore more
Neurelis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Neurelis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Neurelis recently announced quarterly report
Product Launch: Get notified when Neurelis launches new products
Website visits: Recent activity has been detected on your website
Check out if Neurelis is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Neurelis
Funding: Get notified immidiatlly once Neurelis has new funding data
Click to see if Neurelis had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Neurelis has recently received funding, and reach out quickly before it becomes old news!
Neurelis, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Neurelis
Compare insights from companies similar to Neurelis, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Neurelis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Neurelis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Neurelis.
Neurelis financials insights
Gather financial insights about Neurelis, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series D
$114M
Neurelis Tech Stack
A closer look at the technologies used by Neurelis
See more technologies
Most Recent Scoops
Open Position
Open Position
Event
Product Marketing, Events, Sales, Safety, Public Health, Field /Outside Sales, Field Marketing, Health & Safety, Healthcare Operations, Operations, Patient Experience
Open Position
Person-Based
Award
Neurelis News & Media
NEURELIS TO PRESENT ANALYSES OF IMMEDIATE-USE SEIZURE TREATMENT AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING
Presentations to highlight analyses of both seizure termination and healthcare resource utilization as they relate to use of diazepam nasal spray SAN DIEGO, April 16, 2026 /PRNewswire/ -- Neurelis, Inc., today announced details of two poster presentations at the American Academy of...NEURELIS TO PRESENT CLINICAL DATA AT AMERICAN EPILEPSY SOCIETY ANNUAL MEETING
Collection of eight posters include analyses of data from studies of diazepam nasal spray in treatment of episodes of frequent seizures in people with epilepsy aged 2-65 years SAN DIEGO, Dec. 5, 2025 /PRNewswire/ -- Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray),...NEURELIS TO PARTICIPATE IN SOFIE'S JOURNEY EPILEPSY AWARENESS DAY AND EDUCATION EXPO AT DISNEYLAND® RESORT
Company will be joined by its Ambassadors to engage epilepsy community and share their journeys SAN DIEGO, Nov. 10, 2025 /PRNewswire/ -- Neurelis, Inc., the innovator behind VALTOCO® (diazepam nasal spray), today announced it will join the epilepsy community at the 13th Annual Sofie's...NEURELIS TO PRESENT STUDY OF NRL-1049, A RHO KINASE (ROCK) INHIBITOR WITH POTENTIAL TO TREAT SYMPTOMATIC CEREBRAL CAVERNOUS MALFORMATIONS (CCM), AT ANNUAL CCM MEETING
Phase 1 clinical study data on NRL-1049 shows dose-proportional increase in exposure and favorable safety profile SAN DIEGO, Nov. 6, 2025 /PRNewswire/ -- Neurelis, Inc., today announced it will present at the Alliance to Cure Cavernous Malformation (CCM) 21st International CCM Scientific...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Neurelis
Sign Up For FreeTo access detailed company insights
Neurelis is changing the way central nervous system (CNS) disorders are treated. In 2007, a small group of individuals who were passionate about helping patients started Neurelis in San Diego, California. Our founders identified significant unmet needs for patients, care partners, and healthcare providers in the treatment of CNS disorders and are w... Read More
